Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Rectal Neoplasms 3Stomach Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Skin Neoplasms 1Sarcoma, Ewing 1Radiation Injuries 1Postoperative Complications 1Pilonidal Sinus 1Osteosarcoma 1Neoplasms 1Lymphatic Metastasis 1Low Anterior Resection Syndrome 1Gestational Trophoblastic Disease 1Fatigue 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma 1Breast Neoplasms 1

Interventions

Doxorubicin 3Methotrexate 2Cisplatin 2merphos 1cabozantinib 1apatinib 1Zoledronic Acid 1X-Rays 1Triptorelin Pamoate 1Surgical Procedures, Operative 1Platinum 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Ifosfamide 1Drug Therapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Osteosarcoma × Surgical Procedures, Operative × Clear all
NCT05691478 2026-05-27

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

National Cancer Institute (NCI)

Phase 2/3 Recruiting
1,122 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡